Detalhe da pesquisa
1.
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol
; 204(2): 525-533, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905734
2.
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
Hematol Oncol
; 42(1): e3235, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942762
3.
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders.
Crit Rev Clin Lab Sci
; 60(2): 83-100, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066070
4.
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
Br J Haematol
; 200(3): 306-314, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261137
5.
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Br J Haematol
; 202(4): 776-784, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386877
6.
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Hematol Oncol
; 41(4): 631-643, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994552
7.
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Br J Haematol
; 196(3): 589-598, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34632572
8.
First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma.
Hematol Oncol
; 40(2): 297-301, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845733
9.
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Hematol Oncol
; 40(4): 588-595, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35611996
10.
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.
Br J Haematol
; 193(2): 299-306, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200406
11.
Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluation.
Hematol Oncol
; 39(5): 639-649, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494300
12.
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma.
Ann Hematol
; 100(5): 1231-1239, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629152
13.
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era.
Br J Haematol
; 184(5): 753-759, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30515755
14.
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
Br J Dermatol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576352
15.
Lesions mimicking colonic polyposis.
Gastrointest Endosc
; 97(6): 1165-1166, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682422
16.
Zanubrutinib joins the CLL treatment buffet.
Lancet Oncol
; 23(8): 965-967, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810752
17.
Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Am J Hematol
; 92(4): 375-380, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28120419
18.
Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact.
Haematologica
; 106(6): 1754-1757, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147939
19.
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients.
Eur J Haematol
; 106(3): 428-432, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247499
20.
Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?
Br J Haematol
; 183(1): 127-129, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832940